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Abstract 
Longitudinal neuroimaging studies in major depression have revealed cortico-limbic 
abnormalities which are modulated by treatment. We performed a systematic review and meta-
analysis of psychotherapy treatment studies measuring neural function and metabolism using 
fMRI, PET, SPECT and MRS. Seventeen studies were included in the systematic review, total 
of 200 major depression participants (mean age 37.6 years), all medication free, and 116 
healthy controls (mean age 36.4 years).  Neuroimaging assessments were performed prior to 
initiation of treatment and following course of treatment. Treatment durations were: 16-30 weeks 
for CBT, 11 weeks for behavioral activation therapy, and up to 15 months for psychodynamic 
psychotherapy.  The meta-analysis consisted of studies in which both groups had same serial 
scans and comparable tasks; total of 5 studies with visual presentation tasks of emotional 
stimuli: 55 patients (mean age: 38.7 years) and 55 healthy controls (mean age: 36.3 years). The 
meta-analysis revealed a significant group by time effect in left rostral anterior cingulate, in 
which patients showed increased activity following psychotherapy while healthy controls showed 
a decrease at follow up. Longitudinal treatment effects revealed reduced left precentral cortical 
activity in major depression. Findings could be indicative of improvements in emotion 
responsivity that may be achieved following psychotherapy. 
 
Keywords 
meta-analysis; neuroimaging; major depressive disorder; cognitive behavioral therapy; 
psychodynamic; interpersonal, psychotherapy; psychological intervention  
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1. Introduction 
Major depression is the most prevalent of the mental health disorders, affecting an estimated 
350 million people globally, and is the leading cause of disability worldwide (Vos et al., 2015). 
The disorder is associated with a high risk of relapse, which is about 50% following the first 
depressive episode and increases up to 80% after two episodes (Mueller et al., 1999). 
Treatments which can reduce the risk of a depressive relapse are essential for supporting 
recovery and for maintaining interpersonal, social and occupational functioning. While 
antidepressant medication has demonstrated efficacy in reducing the risk of relapse, a course of 
treatment with cognitive behavioral therapy is as efficacious in preventing a depressive relapse 
as ongoing treatment with antidepressant medication (Cuijpers et al., 2014), and 
psychodynamic psychotherapy is as efficacious as cognitive behavioral therapy for the 
treatment of major depression (Steinert et al., 2017). 
 
We know that psychological therapies are effective treatments for acute depressive episodes 
and can aid in preventing a depressive relapse, however the mechanisms of these treatments 
are not well understood. The different forms of therapy have been founded on distinct principles, 
which guide the format and procedures in each treatment. Cognitive behavioral therapy 
considers the interrelationship between the affect, behavior and cognitions which predominates 
in depression, namely the low mood, social withdrawal and negative thinking style that are 
characteristic of an acute depressive episode. Cognitive behavioral therapy proposes that 
addressing the cognitive processes and content that underlie the dysfunctional attitudes and 
behavior is a key component in alleviating depressive symptoms (Lorenzo-Luaces et al., 2015; 
Sheppard and Teasdale, 2000). Behavioral activation therapy was developed as a stand-alone 
component of cognitive behavioral therapy which focuses on engagement and participation in 
constructive reinforcing activities and reduction of avoidance and withdrawal behaviors (Ekers et 
al., 2014).  Interpersonal therapy is based on the premise that maladaptive communication 
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processes negatively impact mood and thus attempts to address the interpersonal problems 
that are common in individuals with depression (Weissman, 2006). Psychodynamic 
psychotherapy seeks to understand the unconscious processes that impact on interpersonal 
relationships and day to day functioning in order to help the individual to become aware of these 
processes and to then be able to modify their responses and behaviors (de Maat et al., 2009). 
 
While different forms of psychological therapies propose distinct formulations, there are also 
some common factors which contribute to their efficacy in improving depressive symptoms. For 
example, therapeutic alliance, which is the relationship between the patient and therapist, has 
been shown to mediate the clinical outcome in psychotherapy (Flückiger et al., 2012; Horvath 
and Luborsky, 1993; Krupnick et al., 2006; Lorenzo-Luaces et al., 2015), as well as with 
pharmacological and placebo treatments (Krell et al., 2004; Leuchter et al., 2014). The 
contribution of common and specific factors to the efficacy of each form of psychotherapy has 
not been established. If we could identify the components which are most important for their 
clinical effectiveness, then we may be able to improve clinical outcomes by optimizing these 
features and we could determine whether there are specific components which are more 
beneficial for specific features in major depression.  
 
Investigations of mechanisms of psychological therapies in depression though have been 
largely based on self-report and behavioral measures.  Self-report measures are subjective and 
inherently biased, and behavioral measures may not be able to offer the necessary precision 
and accuracy.  Neuroimaging offers the potential to identify the neural processes that underlie 
the psychological therapies. Study designs that consist of measures before and following the 
intervention are able to demonstrate treatment effects when the neural responses that change 
with the clinical outcome are considered because the effects of treatment would be expected to 
be most evident in those patients whose depressive symptoms show the greatest improvement.  
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In order to examine the mechanisms of the treatment, a mediator would need to demonstrate an 
effect on the clinical outcome, and importantly a change in the mediator would need to precede 
the change in the dependent variable (Kraemer et al., 2002). Thus, it would be necessary to 
acquire serial measurements at: baseline prior to the intervention, early in the course of therapy 
before a change in symptoms occurs, as well as following the course of therapy.  
 
The interplay between the amygdala and prefrontal regions is important for healthy emotional 
regulation which involves prefrontal modulation of amygdala responses (Costafreda et al., 
2008).  However, major depression is associated with reduced connectivity between the 
amygdala and the dorsal anterior cingulate cortex (Costafreda et al., 2013).  If there are distinct 
mechanisms in each of the psychological therapies, it would be expected that there would be 
distinct neural mediators and correlates.  Proposed mechanisms for different forms of 
psychological therapy have generally been based on data from the early longitudinal 
neuroimaging studies. Cognitive behavioral therapy is proposed to increase inhibitory cortical 
control from the prefrontal cortex, in particular the dorsolateral prefrontal cortex (DeRubeis et 
al., 2008).  Behavioral activation is proposed to increase reward based behavior, such as 
reward anticipation by increased striatum functioning and reward feedback involving 
dorsolateral prefrontal and orbitofrontal regions (Dichter et al., 2009).  Reductions in subgenual 
anterior cingulate activity following psychodynamic psychotherapy have been proposed to 
reflect the overcoming of repressed emotions and lessening in unconscious guilt (Abbass et al., 
2014) 
 
Longitudinal neuroimaging studies of psychological therapies have most commonly consisted of 
serial scans prior to and following a course of treatment.  Mixed findings have been revealed 
though, for example amygdala activity at baseline, prior to treatment, has been reported as 
increased (Buchheim et al., 2012; Fu et al., 2008), decreased (Ritchey et al., 2011), as well as 
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showing no differences (Yoshimura et al., 2013) in major depression relative to healthy 
participants. These effects were then followed by reductions in amygdala activity following 
cognitive behavioral therapy (Fu et al., 2008), behavioral activation therapy (Dichter et al., 2009) 
as well as to long term psychodynamic psychotherapy (Buchheim et al., 2012).  In prefrontal 
regions, increases (Fu et al., 2008), but also decreases (Buchheim et al., 2012), in anterior 
cingulate activity have been reported, as well as increases in the medial prefrontal cortex 
following cognitive behavioral therapy (Ritchey et al., 2011; Yoshimura et al., 2013). 
 
Such variances can be due in part to differences in symptom profiles and concurrent 
antidepressant medications, experimental paradigms, scanning procedures and treatment 
durations.  An experimental task that involves passive viewing or implicit processing of 
emotional stimuli is generally associated with greater probability of amygdala activation as 
compared to active task instructions, tasks needing increased attentional effort or a task that 
includes a language component (Costafreda et al., 2008), which may then have an impact on 
any subsequent modulation by therapy.  Individual studies tend to generate modest effect sizes 
due to the relatively small sample sizes (Costafreda, 2012).  Meta-analysis of treatment studies 
can detect consistent findings across studies and may provide more robust conclusions. 
 
We performed a systematic review and meta-analysis of the neural correlates of psychological 
therapies in major depression. We sought to build on previous systematic reviews, which had 
not conducted a quantitative analysis (Quidé et al., 2012), or was limited to psychodynamic 
psychotherapy (Abbass et al., 2014) or to cognitive behavioral therapy (Franklin et al., 2015).  
Previous meta-analyses had combined  depression and anxiety disorders (Messina et al., 2013) 
or had combined studies using a number of paradigms, as well as including a study in which 
patients had not responded to a trial of antidepressant medication and were taking them during 
cognitive behavior therapy (Boccia et al., 2016). We sought to address these confounds of 
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combining major depression with anxiety disorders, combining the effects of psychological 
therapy with the effects of pharmacological therapy, and combining cognitive and affective 
processing tasks.  
 
In the present systematic review and meta-analysis, we examined the neural effects and 
potential mechanisms of psychological therapies in major depression. We limited the samples to 
major depression; examined the forms of therapy: cognitive behavioral therapy, behavioral 
activation therapy, interpersonal therapy and psychodynamic psychotherapy; and included the 
neuroimaging methods: functional MRI, PET, SPECT and magnetic resonance spectroscopy.  A 
variety of neuroimaging tasks were assessed in the systematic review, but the meta-analysis 
consisted only of studies in which both the patient and healthy control groups underwent the 
same serial scans and comparable tasks. The only studies which met these criteria had applied 
visual affective processing tasks. Furthermore, the meta-analysis directly addressed the 
potential of a positive reporting bias by including both whole brain and region of interest studies 
as well as studies which failed to show any baseline group differences.   
 
We examined the following contrasts: (1) to determine the effects of therapy in a group by time 
interaction analysis in major depression and healthy participants, which accounts for potential 
confounds of time and repeated scans; (2) to assess the effects of therapy in a pre-treatment 
(baseline) versus post-treatment contrast in patients with major depression; and (3) to assess 
the specific neural correlates of therapy in a correlation of the change in neural responses 
following treatment with the change in depressive symptom severity.  
 
2. Methods 
2.1. Systematic review strategy and selection criteria 
8 
 
Studies investigating psychological treatment effects on neural activity were identified through 
searches of PubMed and Scopus from January 1986 to 1 May 2017 using the search terms: 
“depression”, "MRI" or “PET” or “SPECT”; and “psychotherapy” or "interpersonal therapy” or 
“cognitive behavioral therapy” or “psychodynamic”, limited to ‘humans’ and ‘English’ language. 
References of retrieved papers, reviews (Abbass et al., 2014; Gülfizar, 2012; MacQueen, 2009), 
systematic reviews (Roffman et al., 2005; Weingarten and Strauman, 2015), and meta-analyses 
(Boccia et al., 2016; Franklin et al., 2015) were also examined, including Springer Online 
Archives Collection.  Authors were contacted for clarification about their studies, for example if 
the sample included participants with primary comorbid disorders at the time of recruitment or 
who were taking concomitant medications. We followed the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Figure 1) (Liberati et al., 2009).  
 
Inclusion criteria were: 1) adults 18 - 65 years; 2) diagnosis of major depression, ascertained by 
standard diagnostic criteria (DSM, ICD), that was a first episode or recurrent; 3) participants 
who were either medication free or drug naïve; 4) treatment with a psychological therapy for a 
minimum of 6 weeks including: CBT, cognitive analytic therapy, interpersonal therapy, 
psychodynamic and behavioral activation therapy; 5) sample size of over 5 participants in the 
treatment group; 6) neuroimaging assessments prior to the initiation of treatment at baseline 
and following the course of treatment (i.e., psychotherapy for > 6 weeks); and 7) neuroimaging 
assessment, namely neural activity, connectivity or metabolism (i.e., glucose, serotonin and 
GABA) using functional MRI (fMRI), positron emission tomography (PET), single photon 
emission computed tomography (SPECT) or magnetic resonance spectroscopy (MRS); 8) 
English language publications.  Exclusion criteria were: 1) comorbid illnesses as primary 
diagnoses at the time of recruitment;  2) other forms of depression i.e., chronic depression, 
treatment resistant depression, bipolar depression, old age depression; and 3) concurrent 
therapy or treatment procedures. 
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2.2. Data extraction 
Demographic characteristics, forms of therapy, neuroimaging tasks and study findings were 
extracted (Table 1). Quality was evaluated using the criteria of the Quality Assessment Tool for 
Quantitative Studies (Supplementary Table 1) (QATQS; National Collaborating Centre for 
Methods and Tools) (Thomas et al., 2004). 
 
From the neuroimaging data, the following data were extracted: sample size, contrasts 
examined, normalization template (MNI or Talairach), location information (x, y, z coordinates of 
the brain regions), field of view (region of interest (ROI) or whole brain), statistical threshold, 
threshold type (p, F, z, t) and value, filter value (full width at half maximum) (van der Velde et al., 
2013).  
 
Depression severity in the included studies was assessed by standardized rating measures 
(Beck Depression Inventory (BDI), Montgomery-Åsberg Depression Rating Scale (MADRS) and 
the Hamilton Rating Scale for Depression (HRSD). The change in depressive severity was 
determined as the difference between post- and pre- treatment depression severity scores. To 
compare depression severity across studies which used different rating measures, the scores 
were normalized by dividing the reported score by the maximum possible score on the rating 
scale. 
 
2.3. Meta-analysis 
The meta-analysis consisted of three contrasts: 1) group by time interactions between major 
depression and healthy participants; 2) pre-treatment (baseline) versus post-treatment 
responses in patients with major depression; and 3) correlation of the neural changes with 
change in depressive severity from pre-treatment to post-treatment. Studies which included 
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healthy participants who had undergone the same scans at the same timepoints were included 
to account for potential effects of repeated scanning and changes over time. 
 
The meta-analysis was performed using the parametric coordinate-based meta-analysis method 
(PCM) (Costafreda, 2012), which provides quantitative meta-analytic summaries that address 
the limitations of methods which tend to treat studies with different statistical thresholds as 
equivalent.  We were able to incorporate both region of interest and whole brain analyses and to 
integrate regions reported as significant in the original studies as well as sub-threshold non-
significant findings to integrate the real but often modest effect sizes into the summary map. 
This allowed us to generate an unbiased valid pooled effect size summary of studies with 
varying thresholds while minimizing potential biases towards a positive effect. 
 
Talairach coordinates were converted to the MNI coordinate system by using a non-linear 
transformation approach (Brett et al., 2001).  Differing statistical thresholds were converted into 
corresponding Z scores to achieve a common measure of effect size.  Non-significant findings 
were reported by intervals with the values for the unknown measurements that were less than 
the reported statistical thresholds (van der Velde et al., 2013).   
 
Effect size summary output maps were produced separately for the three contrasts. The output 
was obtained after correcting for multiple comparisons, using a statistical threshold of P < 0.05 
false discovery rate (FDR). Only clusters of voxels which were larger than the chosen extent 
threshold of 50 mm3 have been reported. 
 
3. Results 
3.1. Characteristics of included studies 
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The search criteria yielded 99 references in Scopus and 488 references in PubMed databases, 
and 7 additional manuscripts were identified through reference lists of relevant articles. 
Following exclusion of duplicate titles, 81 studies were screened. 
 
Seventeen studies met the inclusion and exclusion criteria and were included in the systematic 
review, consisting of a total of 200 participants with major depression (mean age 37.6 years) 
and 116 healthy controls (mean age 36.4 years).  All studies had used DSM or ICD criteria to 
diagnose major depression. 
 
Four forms of psychological therapies had been examined in these studies: CBT (n = 9 studies, 
including one internet CBT (iCBT), behavioral activation therapy (BAT) (n = 2), interpersonal 
therapy (IPT) (n = 2) and long term psychodynamic therapy (n = 4). The duration of treatment 
ranged from 11-30 weeks for CBT, 11 weeks for BAT, 12-16 weeks for IPT and 4 -12 months for 
long term psychodynamic therapy. 
 
The neuroimaging assessments were generally performed prior to the initiation of treatment at 
baseline and following the course of treatment for all studies expect one study which acquired 
neuroimaging data during treatment at 6 weeks (Martin et al., 2001).  Neuroimaging 
assessments were: task-based functional MRI (n = 7) (Buchheim et al., 2012; Dichter et al., 
2009; Dichter et al., 2010; Fu et al., 2008; Ritchey et al., 2011; Sankar et al., 2015; Wiswede et 
al., 2014); resting state functional MRI (n = 1) (Shou et al., 2017); FDG-PET  to measure resting 
state regional glucose metabolism (n = 3) (Brody et al., 2001; Goldapple et al., 2004; Kennedy 
et al., 2007); resting state SPECT to measure cerebral blood flow using 99mtechnetium-labelled 
hexamethyl propylene amine oxim HMPAO (n = 1) (Martin et al., 2001), serotonin transporter 
(SERT) binding using [123 I]-ADAM (n = 1)  (Amsterdam et al., 2013) and SERT and dopamine 
transporter (DAT) densities using [123I]nor--CIT (n = 1) (Lehto et al., 2008); MRS  to measure 
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cortical  aminobutyric acid (GABA) and glutamate concentrations (n = 1) (Sanacora et al., 
2006) and PET imaging to examine striatal and thalamic D2/3 receptor binding using 
[11C]raclopride (n = 1) (Hirvonen et al., 2011), and 5-HT1B receptor binding using 
[11C]AZ10419369 (n = 1) (Tiger et al., 2014). 
 
Ten studies included a healthy control group who had also undergone the same follow up scans 
as the patient group: 3 studies were resting state, consisting of FDG-PET (Brody et al., 2001), 
[123 I]-ADAM SPECT (Amsterdam et al., 2013) and resting state functional MRI (Shou et al., 
2017); and 7 studies applied a functional task (Buchheim et al., 2012; Dichter et al., 2009; 
Dichter et al., 2010; Fu et al., 2008; Ritchey et al., 2011; Sankar et al., 2015; Wiswede et al., 
2014). The functional task was an affective processing task in 5 studies (Buchheim et al., 2012; 
Dichter et al., 2009; Dichter et al., 2010; Fu et al., 2008; Ritchey et al., 2011), statements 
referring to dysfunctional relationship themes in 1 study (Wiswede et al., 2014), and statements 
assessing dysfunctional attitudes in 1 study (Sankar et al., 2015). 
 
The meta-analysis was conducted on the studies which had comparable tasks: 5 studies which 
used an affective processing task involving visual presentation of emotional stimuli (Buchheim 
et al., 2012; Dichter et al., 2009; Dichter et al., 2010; Fu et al., 2008; Ritchey et al., 2011), 
consisting of 55 participants with major depression (mean age: 38.7 years) and 55 healthy 
controls (mean age: 36.3 years). 
 
3.2. Systematic review: qualitative analysis 
Following treatment with CBT, decreased activity during resting state was observed in the 
prefrontal cortex, specifically in the ventrolateral prefrontal cortex (VLPFC) (BA11/47) 
(Goldapple et al., 2004; Kennedy et al., 2007), dorsolateral prefrontal cortex (DLPFC) (BA9/46) 
(Goldapple et al., 2004) and dorsomedial prefrontal cortex (dmPFC) (Kennedy et al., 2007) in 
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patients with major depression, while increased activity in the ventromedial prefrontal cortex 
was found in response to an affective processing task (Ritchey et al., 2011). Following 
psychodynamic psychotherapy, decreased medial prefrontal cortex (mPFC) activity was also 
reported (Buchheim et al., 2012; Wiswede et al., 2014) and more generally in the prefrontal 
cortex following IPT (Brody et al., 2001).  
 
In the cingulate cortex, increased activity was noted following CBT therapy in the dorsal anterior 
cingulate cortex (ACC) (BA24) in a resting state PET study (Goldapple et al., 2004) and (BA 24, 
32) and during an affective processing task (Fu et al., 2008), while activity in the subgenual 
ACC was found to decrease following CBT as measured during resting state (Kennedy et al., 
2007), as well as following psychodynamic psychotherapy (Buchheim et al., 2012). In the poster 
cingulate, increases following CBT were reported during an affective processing task (BA23, 30, 
31) (Fu et al., 2008) and following IPT (Martin et al., 2001), while decreases were also noted 
following CBT as measured during resting state (BA 31) (Goldapple et al., 2004) and during the 
DAS task (BA 30) (Sankar et al., 2015). 
 
In the hippocampus, increased arousal related responses were found in an IAPS picture task 
(Ritchey et al., 2011), as well as increased activity during resting state (Goldapple et al., 2004), 
and more generally in the medial temporal region (Amsterdam et al., 2013).  However, 
decreased hippocampal activity has also been observed following CBT in response to an 
affective processing task (Fu et al., 2008) and following psychodynamic psychotherapy in 
response to emotional stimuli (Buchheim et al., 2012). 
 
In the amygdala, decreased activity was reported following CBT during an affective processing 
task (Fu et al., 2008), as well as following psychodynamic psychotherapy during a sentence 
processing task (Wiswede et al., 2014) and in response to emotional stimuli (Buchheim et al., 
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2012).  At rest, major depression was associated with greater amygdala connectivity with the 
inferior frontal gyrus following CBT as compared with healthy controls (Shou et al., 2017). 
 
In the striatum, there were no changes in either DAT densities as measured with [123I]nor--CIT 
(Lehto et al., 2008) or in D2/D3 binding potential as measured with [11C]raclopride (Hirvonen et 
al., 2011) following psychodynamic psychotherapy, nor were there any changes observed in 
midbrain SERT densities measured using [123I]nor--CIT following psychological therapy (Lehto 
et al., 2008). 
 
3.3. Meta-analysis 
3.3.1. Group by time interaction effect, putative effects of psychological therapy 
The group by time interaction effect could be investigated from 4 studies (n = 44 major 
depression, n = 48 healthy participants) as 1 study (Ritchey et al., 2011) did not examine group 
by time interaction effects.  All the studies had applied a whole brain analysis (Buchheim et al., 
2012; Dichter et al., 2009; Dichter et al., 2010; Fu et al., 2008). 
 
The meta-analysis revealed a significant group by time interaction effect in the left rostral 
(pregenual) anterior cingulate, in which there was an increase in activity following psychological 
therapy in patients with major depression while healthy controls showed a reduction in activity at 
the follow up scan (MNI coordinates, x = -6, y = 34, z = 4; volume 208 mm3; Z = -2.76; r = -0.40) 
(Figure 2).   
 
3.3.2. Main effect in patients with major depression   
Four of the 5 studies included in the meta-analysis examined the longitudinal neural changes 
with treatment in patients (n = 39 major depression) (Dichter et al., 2009; Dichter et al., 2010; Fu 
et al., 2008; Ritchey et al., 2011).  One study applied a ROI analysis (Ritchey et al., 2011), and 
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3 studies used a whole brain analysis (Dichter et al., 2009; Dichter et al., 2010; Fu et al., 2008), 
however the pre-treatment versus post-treatment analysis for these studies was only performed 
with those regions which had a significant group by time interaction, thereby was considered as 
a ROI analysis. 
 
The meta-analysis found decreased activity in the left precentral gyrus following treatment with 
CBT (MNI coordinates, x = -34, y = -28, z = 60; volume 616 mm3; Z = -4.24; r = -0.49) (Figure 
3).  Clusters in the inferior parietal region, including in the supramarginal gyrus, did not meet the 
50 mm3 extent threshold. No regions showed an increase in response following psychotherapy.   
 
3.3.3. Correlations with improvements in depressive severity 
As only one study had examined the association between changes with serial scans and 
depressive symptoms (Buchheim et al., 2012), this contrast was not examined. 
 
4. Discussion 
We sought to delineate the neural effects of psychological therapies in longitudinal prospective 
treatment studies in major depression. The systematic review consisted of studies which had 
acquired serial neuroimaging scans prior to and following a course of treatment with a 
psychological therapy.  The meta-analysis was conducted in studies which had a sufficient 
number of comparable tasks and in which both the patient and healthy control groups had 
undergone the same set of scans, in order to take into account effects of repeated task 
presentations and effects of time.  The studies included in the meta-analysis had used affective 
processing tasks with visual presentation of emotional stimuli.  The meta-analysis revealed a 
significant interaction effect of treatment in the rostral anterior cingulate in major depression as 
compared to healthy participants and a significant main effect of treatment in major depression 
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in the precentral gyrus.  The findings provide some insight into the potential mechanisms and 
specificity of the treatment effects of psychological therapies. 
 
The group by time interaction analysis revealed a significant effect in the left rostral anterior 
cingulate gyrus, in which patients with major depression showed increased activity following 
psychological therapy while healthy controls showed reduced activity at the follow up scan.  The 
ventral-rostral regions in the anterior cingulate have strong connections with core emotion 
processing regions, in particular the amygdala, and is purported to have a regulatory function on 
limbic regions (Etkin et al., 2011), as well as in reward processing and decision making 
(Botvinick, 2007; Bush et al., 2000).  Healthy emotion regulation is linked to suppression of 
amygdala activity through communication with the rostral and dorsal anterior cingulate and 
dorsolateral prefrontal cortices (Banks et al., 2007; Carballedo et al., 2011; Costafreda et al., 
2008).  A characteristic feature of depression is the inability to disengage from negative stimuli 
once they have secured attention (Gotlib and Joormann, 2010), which is evident in the impaired 
connectivity between the anterior cingulate and amygdala in major depression (Costafreda et 
al., 2013). 
 
Cognitive control of emotional experience may be attempted using a number of strategies of 
varying effectiveness: cognitive reappraisal, which involves cognitive re-interpretation of the 
presented stimuli; suppression, which is an active attempt to inhibit the emotional response; or 
negative ruminations, which is the process of repetitive passive thinking about the experience of 
distress (Garnefski and Kraaij, 2006; Nolen-Hoeksema and Davis, 1999). While each process 
may be used at different times, the predominant use of suppression and negative ruminations 
has detrimental effects on mood and cognition (Dillon et al., 2007), and healthy emotional 
regulation includes cognitive reappraisal.  Moreover, increased anterior cingulate activity is 
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predictive of a good clinical response to pharmacological as well as CBT treatments for major 
depression (Fu et al., 2013). 
 
The increase in rostral anterior cingulate activity following the psychological therapies could 
reflect improvements in emotion regulation, with the further possibility that a mechanism is 
improvement in cognitive reappraisal.  However, cognitive reappraisal was not an explicit 
component of the affective processing studies that were included in the present meta-analysis.  
Furthermore, Rubin-Falcon and colleagues (2018) found that it was reduced activation, 
including in the subgenual anterior cingulate, which was associated with improved clinical 
outcome following CBT during an emotion regulation task for negative autobiographical 
memories.  
 
It is possible that the activity in the rostral anterior cingulate may reflect increased emotional 
responsivity to the affective processing task, perhaps with an implication of self-referential 
processing (Nejad et al., 2013).  Meta-analyses demonstrate the prognostic significance of 
increased activity in the rostral anterior cingulate cortex with the likelihood of clinical response 
(Fu et al., 2013; Pizzagalli, 2011), and psychological therapy, in particular CBT, is associated 
with a reduced risk of depressive relapse (Cuijpers et al., 2014). Most broadly, the findings 
suggest that there are cortical top down effects of psychological therapy (Goldapple et al., 
2004), although this cannot be empirically demonstrated in the present meta-analysis in the 
absence of accompanying subcortical modulations. 
 
The specificity of the effects of the different psychological therapies warrants further 
investigation as the individual studies revealed increased anterior cingulate activity following 
short term behavioral activation or cognitive behavioral therapy (Dichter et al., 2009; Fu et al., 
2008). This finding is also consistent with resting state PET studies, which reported increased 
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anterior cingulate activity following CBT (Goldapple et al., 2004), though long term 
psychodynamic psychotherapy was associated with a reduction in anterior cingulate activity 
(Buchheim et al., 2012). 
 
The meta-analysis also revealed that a longitudinal treatment effect of psychotherapy was 
reduced activity in the left precentral cortex in major depression. The precentral cortex is 
primarily associated with motor functions, but it may also be involved in cognitive functioning 
(Zhang et al., 2012) as it is engaged during negative attributional bias (Blackwood et al., 2000) 
and working memory load (de Fockert et al., 2001).  In major depression, precentral cortical 
activation has been observed in response to working memory load (Walsh et al., 2007) as well 
as to negative emotional pictures (Ritchey et al., 2011) and facial processing of sad, angry 
(Frodl et al., 2009; Fu et al., 2004) and fearful (Arnone et al., 2012) expressions in major 
depression (meta-analysis: (Zhao et al., 2014). Longitudinal studies have further demonstrated 
that emotion-regulation dependent reductions in the precentral gyrus after treatment was 
associated with improved treatment outcome (Rubin-Falcone et al., 2018).  A key mechanism in 
cognitive behavioral therapy is cognitive change, whereby the treatment improves the 
maladaptive cognitions that are characteristic of major depression (Beck, 1979).  A reduction in 
precentral activation following psychotherapy could be consistent with an improvement in 
negative cognitive styles with treatment. 
 
While the Boccia et al. (2016) meta-analysis also reported increased activation in prefrontal and 
cortical regions, the location of the effects differed as they included the left inferior and superior 
frontal, middle cingulate, middle temporal, and bilateral precentral regions. However, the studies 
in the meta-analysis (Boccia et al., 2016) had greater heterogeneity in the scanning paradigms, 
ranging from resting state to task-based studies; in the patient samples, which included 
recurrent as well as treatment resistant forms of depression (Yoshimura et al., 2013); and in the 
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medication status of the samples.  We were able to delineate an interaction effect in the left 
rostral anterior cingulate in response to emotion processing tasks, by including only studies with 
the most comparable scanning paradigms which reduced heterogeneity and increased the 
power to find a significant effect.  
 
In the present meta-analysis, however, we could not examine correlations between changes in 
brain activation and treatment response as only one longitudinal study had examined this 
contrast.  One of the most replicated predictors of clinical response is anterior cingulate activity, 
in which increased baseline anterior cingulate activity is predictive of clinical response (meta-
analysis (Fu et al., 2013)).  Increases in anterior cingulate activity following psychotherapy has 
been associated with improvement in rumination (Yoshimura et al., 2013) and treatment 
response (Goldapple et al., 2004), although improvements in depression severity was also 
associated with decreases in anterior cingulate following long-term psychodynamic therapy 
(Buchheim et al., 2012), perhaps indicative of specificity of effects of the different forms of 
psychological therapies.  Longitudinal neuroimaging studies have further revealed reductions in 
bilateral cerebellum that were correlated with improvement in depression (Rubin-Falcone et al., 
2018). Although the cerebellum is usually associated with motor control, language and attention, 
cerebellar engagement has also been noted during sad mood induction by musical pieces 
(Mitterschiffthaler et al., 2007). 
 
The systematic review identified that there was attenuated activity in the amygdala following 
both CBT and psychodynamic psychotherapy which was observed with emotional task-based 
neuroimaging studies (Buchheim et al., 2012; Fu et al., 2008; Wiswede et al., 2014) rather than 
resting state studies. While this finding has been noted in meta-analysis of pharmacological 
treatment studies (Delaveau et al., 2011; Fitzgerald et al., 2008), this was not evident in the 
present or Boccia et al. (2016) meta-analyses.  Whether pharmacological treatments have 
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greater effects in limbic and subcortical regions (Boccia et al., 2016; Delaveau et al., 2011; 
Fitzgerald et al., 2008) as compared to psychological treatments is intriguing, but requires 
further investigation because the number of pharmacological studies to date has been several 
fold greater than the number of psychological treatment studies. 
 
While all the studies included in the meta-analysis used emotional processing tasks, there was 
some variability in the valence of the stimuli, in which one study used a reward processing task 
(Dichter et al., 2009).  As well, limited effects were observed from the serotonin and dopamine 
transporter or dopamine binding studies (Hirvonen et al., 2011; Lehto et al., 2008), although 
there were only a few studies. 
 
Limitations of the present study include the inability to determine the specificity of the observed 
treatment effects, despite the observed group by time interaction effects, because none of the 
studies had a patient group receiving a placebo form of treatment. The inclusion of only 
published data might have inadvertently introduced a bias, however we were able to incorporate 
both ROI and whole brain analyses and to account for variations in sample size, statistical 
thresholds and smoothing kernel, and the PCM method allows integration of sub-threshold non-
significant findings (Costafreda, 2012), in contrast to the activation likelihood estimation method, 
which assumes that a non-significant finding is the same as having an effect size of zero, as 
applied in Boccia et al. (2016) meta-analysis.  Due to the limited number of longitudinal studies 
meeting eligibility criteria, the analyses were restricted to two contrasts, and pre-post treatment 
designs could implicate neural changes that are not necessarily related to the treatment 
mechanism.  Study designs that examine changes in neural responses which correlate with 
changes in clinical symptoms are important to delineate potential mechanisms.  Another related, 
yet important study design that is seldom investigated is group by time interaction effects 
between responders and non-responders. 
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Furthermore, the forms of psychotherapy had a range of treatment durations. As a general 
issue, the length of treatment is based on guidelines for the specific form of psychotherapy, and 
some are specified in evidence-based guidelines (ex. National Institute for Health and Clinical 
Excellence (NICE) Guidelines in the United Kingdom), while some durations are governed by 
individual therapeutic contracts or insurance coverage.  The NICE Guidelines for moderate to 
severe depression, for instance, recommend 3-4 months of treatment with CBT, BAT or IPT, or 
longer durations (4-6 months) for psychodynamic psychotherapy.  In the present meta-analysis, 
treatment durations using CBT (Sankar et al., 2015, Fu et al., 2008) and BAT (Dichter et al., 
2009, 2010) were in line with the recommended guidelines. However, studies have not 
consisted of serial fMRI scans at regular intervals during their treatment.  Hence, it is difficult to 
ascertain the average length of time in which one can expect to start seeing significant neural 
changes.  We propose that it is possible for some neural changes to be evident early on, before 
subjective improvements in mood are reported, as observed with treatment with antidepressant 
medication (Fu et al., 2015).  
 
 
In summary, treatment with psychological therapy was associated with an increase in rostral 
anterior cingulate activity during emotion processing tasks in major depression in comparison to 
healthy participants. The finding is a suggestive demonstration of the effectiveness of 
psychological therapy in improving emotion responsivity and regulation in major depression.  
Psychological therapy, in particular CBT, has demonstrated improved rates of depressive 
relapse that is comparable to maintenance pharmacological treatment.  However, whether an 
improvement in treatment outcome is linked with an increase in anterior cingulate activity 
following psychotherapy and with improvements in emotion regulation and appraisal would 
require investigation with specific paradigms that examine these processes in a longitudinal 
22 
 
treatment study.  Understanding the mechanisms of treatments on brain activity has the 
potential for developing diagnostic biomarkers and identifying new targets for beneficial forms of 
treatment.  
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Figure Legends 
 
Figure 1. 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram 
of search strategy. 
 
Figure 2. 
Group by time interaction effects of psychological therapies. There was a significant group by 
time interaction in the left rostral anterior cingulate cortex, in which participants with major 
depression showed increased activity following psychological therapy while healthy participants 
showed a reduction in activity at the follow up scan. Sagittal (x), coronal (y), and axial (x) 
coordinates for each section are presented. Results are P < 0.05 FDR corrected.  
 
Figure 3. 
Longitudinal changes following psychological therapies. There was a main effect of in the left 
precentral gyrus, which showed decreased activity following psychological therapy in major 
depression. The coronal (y) coordinate of each section is presented. There were additional 
regions which did not meet our threshold of 50 mm3 for significance.  Results are P < 0.05 FDR 
corrected. 
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Table 1. Summary of demographic characteristics, psychological therapies and neuroimaging tasks 
 
Study Year Number Age Diagnosis Therapy Sessions       Scan   Imaging Tasks 
  MDD HC MDD HC      Interval   
Resting state 
Amsterdam 2013 20 (15) 10 (7) 41±13 45±11 DSM-IV, SCID CBT 12 12 weeks [123I]ADAM SPECT  
Brody  2001 14 (6) 16 (8)  41±11 36±18 DSM-IV IPT 12 12 weeks FDG-PET  
Goldapple 2004 14 (6) - 41±9 - DSM-IV, DSM-III-R, SCID CBT 15-20 15-20 weeks FDG-PET  
Kennedy  2007 12 (5) - 30±10 - DSM-IV, SCID  CBT 14 14 weeks FDG-PET  
Martin  2001 13 (4) - 38±5 - DSM-IV IPT 16 6 weeks Tc-99m HMPAO SPECT  
Shou 2017 17 18 32±7 31±10 DSM-IV, SCID CBT 12 12 weeks MRI  
Task-based studies 
*Buchheim 2012 16  17 39±12 39±12 DSM-IV, SCID PDT - 15 months fMRI AAP pictures 
*Dichter 2009 12 (6) 15 (6) 39+10 31±10 DSM-IV, SCID BATD 11 15 weeks fMRI wheel of fortune 
*Dichter 2010 12 (6) 15 (6) 39±10 31±10 DSM-IV, SCID BATD 11 15 weeks fMRI IAPS 
*Fu  2008 16 (3) 16 (3) 40±9 39±9 DSM-IV, SCID CBT 16 16 weeks fMRI emotional faces 
*Ritchey  2011 11 (3)   7 (2) 36±10 35±7 DSM-IV, SCID CBT 21 30 weeks fMRI IAPS 
Sankar 2015 16 (3) 16 (3) 40+9 40±9 DSM-IV, SCID CBT 16 16 weeks fMRI dysfunctional attitudes  
Wiswede 2014 18 (4) 17 (3) 40±13 38±12 DSM-IV, SCID PDT -  8 months fMRI interpersonal statements 
Receptor and MRS studies 
Hirvonen 2011   8 (5)            - 41±10 - DSM-IV, SCID PDT 16 16 weeks  [11C]Raclopride PET 
Lehto 2008 11 (0) - 27±7 - DSM-IV, SCID PDT 80 12 months
 [123I]nor--CIT SPECT 
Sanacora 2006   8  - - - DSM, SCID  CBT 12 12 weeks MRS 
Tiger 2014 10 (4) - 48+17 - M.I.N.I iCBT 12 14 weeks  [11C]AZ1041936 PET  
The first author and year of study is presented. Number of participants is presented with number of males in parenthesis. Sessions refers to the 
mean number of therapy sessions which were usually provided weekly, with the exception of Lehto et al. (2008) wherein patients received 2 
psychotherapy sessions per week (total = approximately 80 sessions) and Amsterdam et al. (2013) wherein sessions were twice weekly for the 
first four weeks and weekly thereafter through week 12. Buchheim (2012) reported age (mean, SD) for patients and controls together. Both 
Buchheim (2012) and Wiswede (2014) refer to the number of months of therapy. For Ritchey and colleagues (2011), mean and standard deviation 
values are provided for the initial larger sample that included an additional 11 MDD participants and 7 controls, who did not complete treatment 
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and/or follow up assessment.  Five studies had also included a MDD group that received treatment with antidepressant medication: Brody (10 
participants (5 males)); Goldapple (13 (13)); Kennedy (12 (4)); Martin (15 (4)); Hirvonen (14 (5)). Mean age is presented in years rounded up to 
the nearest year + standard deviation. ‘-‘,not stated/not applicable. Diagnosis refers to the diagnostic criteria used to determine the diagnosis. 
Studies included in the meta-analysis are denoted by an asterix (*). Abbreviations: MDD: major depressive disorder; HC: healthy controls; AAP: 
Adult Attachment Projective Picture System; CBT: cognitive behavioural therapy; IPT: interpersonal therapy; PDT: psychodynamic therapy;  
BATD: Behavioural Activation Therapy for Depression; iCBT: internet cognitive behavioural therapy; SPECT: single photon emission computed 
tomography; PET-FDG: fluorine-18-fluorodeoxyglucose positron emission tomography; fMRI, functional magnetic resonance imaging; PET, 
positron emission tomography; IAPS, International Affective Picture System. The radioligands used for the PET and SPECT studies are reported. 
[123I]-ADAM: measures brain serotonin transporter (SERT) binding; Tc-99m HMPAO: measures cerebral blood flow reflecting brain metabolism; 
[11C] Raclopride: measures D2/3  receptor binding; [123I]nor--CIT: measures SERT and dopamine transporter (DAT) densities; [11C]AZ1041936: 
measures 5-HT1B  binding.  
 
 
 
 
 
 
 
 
 
 
 
